Total Visits

Views
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer83

Select a period of time:

Views

Views
September 20253
October 20251
November 20252
December 20250
January 20262
February 20260
March 20266
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Argentina1
Chile1
Colombia1
United Kingdom1
Libya1
Peru1
Turkey1
 

Top cities views

Views
Ankara1
Bogotá1
Dallas1
La Plata1
Mobile1
Moche1
Viña del Mar1
Zliten1